-
Chronic kidney disease (CKD) is a global public health concern, but its burden in Africa is poorly defined. George et al recently combined individual-level and summary data from multiple African countries to provide a more accurate and precise estimate of CKD prevalence. AJKDBlog’s Interviews Editor, Timothy Yau (@Maximal_Change), recently sat down with an author of the study, Ikechi G. Okpechi (@Ikokpechi), to discuss the implications of their research. Dr. Ikechi Okpechi, PhD, is a [...]
-
Dr. Elias John Elenjickal is a Nephrology Research Fellow and PhD. student at the McGill University Health Centre in Montreal, Canada. He completed his medical degree and internal medicine residency at Goa Medical College, and his nephrology training at Dayanand Medical College, Ludhiana—both in India. He is currently on sabbatical from Christian Medical College (CMC), Vellore, the largest not-for-profit tertiary care institution in South India, where he has served as both a clinician and [...]
-
Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney transplant recipients. In a recent Core Curriculum published in AJKD, the authors review common pretransplant and posttransplant cancers and management strategies to help nephrologists understand and manage the associated risks and optimize diagnosis and treatment. AJKDBlog’s Interviews Editor Timothy Yau chatted with [...]
-
Dr. Natasha Freeman is an Assistant Professor in Nephrology, specializing in glomerular diseases, at Columbia University Irving Medical Center. She received her MD from the Columbia University Vagelos College of Physicians and Surgeons and a MS in Narrative Medicine from Columbia University. She completed her residency in internal medicine at Yale-New Haven Hospital, followed by her fellowship in general nephrology and advanced fellowship in glomerular disease at Columbia University Irving [...]
-
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the September 2026 issue: Utility of Risk Scores for Predicting Stroke and Intracranial Bleeding Across Levels of Kidney Function in [...]
Follow Blog by Email:
NephMadness 2026
-
NephMadness#NephMadness 2026: Blue Ribbon Panel
-
NephMadness#NephMadness 2026: POCUS – Stop Guessing, Start Scanning
-
NephMadness#NephMadness 2026: POCUS Region
-
NephMadness#NephMadness 2026: Thank You
-
NephMadness#NephMadness 2026: Animal House – Cats, Kidneys, and the Art of Surviving on Almost No Water
-
NephMadness#NephMadness 2026: Trolls of Transplantation Region
-
NephMadness#NephMadness 2026: Meet the Gamemakers
-
NephMadness#NephMadness 2026: The Left and Right Kidneys
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIRenal Amyloidosis – What We Need to Consider, Practical Tips
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
-
Atlas of Renal Pathology IIRecurrent and De Novo FSGS Following Kidney Transplantation
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology II: The Ultimate Pathology Teaching Tool Has Arrived
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Cholesterol Emboli
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: Sampling Error in Misdiagnosis
-
Atlas of Renal Pathology IIAcute and Chronic Antibody-Mediated Rejection Represent a Continuum of Endothelial Injury Involving Multiple Immune Mechanisms
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 4
-
Atlas of Renal Pathology IICongenital Nephrotic Syndrome: Finnish Type or Diffuse Mesangial Sclerosis?
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy






